Drugs used in Diabetes Dr Sally Hudson. BIGUANIDES reduce output of glucose from the liver and enhances uptake and use of glucose by muscle cells ExampleADVANTAGESDISADVANTAGESCOSTCaution.

Slides:



Advertisements
Similar presentations
NEW ORAL AGENTS IN DIABETES MANAGEMENT
Advertisements

Oral Hypoglycemic Drugs And Classifications
 GLP -1 (gut hormone) + GIP = incretin effect =Augmentation of insulin after oral glucose  Type 2 diabetics little incretin effect  Reduced GLP-1 secretion.
The New HbA1c HbA1c – DCCT (%) HbA1c – IFFC (mmol/mol)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association.
DIABETES WORKSHOP IN GENERAL PRACTICE Dr John Rochford GP Sharnbrook.
Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
Page 1: Baker IDI Update on therapies for type 2 diabetes.
DIABETES MEDICATION UPDATE A. Sami Wood, MS, RD/LD,CDE Center For Diabetes Education OSUMC.
Diabesity Management Colette Walter, NP. Objectives 1. Pharmacologic management and understanding of treatment related to the overweight diabetic patient.
Glycogen Metabolism Storage and Mobilization of Glucose NUTR 543 – Advanced Nutritional Biochemistry David L. Gee, PhD Professor of Food Science and Nutrition.
Oral Medications to Treat Type 2 Diabetes
Combination Therapy in Type 2 Diabetes
Therapeutics in Diabetes
Chapter 36 Agents Used to Treat Hyperglycemia and Hypoglycemia.
LONG TERM BENEFITS OF ORAL AGENTS
DIABETES MELLLITUS Strategies for Achieving Control in an Office Setting.
Treatment of diabetes:  Life style modification  Insulin  Oral hypoglycemic agents.
Insulin in Primary Care Dr Saqib Mahmud, MRCP(UK), MRCGP.
oral hypoglycemic agents
Oral Hypoglycemic Drugs
Preferred treatment options for patients with Diabetes Dr Jon Tuppen GPwSI Beechwood Surgery Brentwood.
Diabetes Survival Camp – Session 2  You can strive and thrive with diabetes Welcome.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Managing Type 2 Diabetes: Review of Recent Guidelines Gina Ryan, Pharm.D., BCPS, CDE Clinical Associate Professor Mercer University College of Pharmacy.
Insulin Conundrums Veronica Green *p < **p = Epidemiological extrapolation showing benefit of a 1% reduction in mean HbA 1c with a mean.
Drug Development —— Metformin. Diabetes type1 vs type2.
Pharmacology of Diabetes Mellitus 2 Dr Emma Baker Consultant Physician/Senior Lecturer in Clinical Pharmacology.
Oral hypoglycemic drugs
JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. JANUVIA Tablets contain sitagliptin.
TYPE 2 DIABETES MELLITUS Cynthia Brown, MN, ANP, CDE.
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
Type 2 diabetes treatment: Old and New Emily Szmuilowicz, MD, MS Assistant Professor of Medicine Division of Endocrinology Northwestern University.
Oral Hypoglycaemic Agents. Outline 1.What are the available OHG agents and how do they work? 2.Metformin – how much, and how safe? 3.Can I still use TZDS.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
DH206: Pharmacology Chapter 21: Diabetes Mellitus Lisa Mayo, RDH, BSDH.
Pathophysiology in the Treatment of Type 2 Diabetes Newer Agents Part 3 of 5.
Oral hypoglycemic drugs
1 Drugs used for Diabetes Mellitus. 2 Introduction There are 2 types of diabetes mellitus: There are 2 types of diabetes mellitus: Type 1: Insulin-dependent.
#4 Management of Diabetes Mellitus. 5 Components of Diabetes Management 5 Components of Diabetes Management Farrell, M. (2005). Textbook of Medical-Surgical.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
MODERN ART in TYPE 2 DIABETES Ken McHardy CRAIGMONIE HOTEL, INVERNESS 11 TH Nov 2011.
1 ‘Medicines used in the management of Type 2 Diabetes’ Dr Susan McGeoch, Specialist Registrar in Diabetes Sandra Wilson, Diabetes Specialist Nurse.
Focus on Diabetes Mellitus NUR 171. How insulin works dia2.us.elsevierhealth.com/ondemand/archieAnimations/423.flv.
Dr. Mansour Alzahrani. متى اكتشف داء السكري؟ داء السكري في الحضارة الهندية والصينية القديمة اسهامات علماء المسلمين في داء السكري.
Oral hypoGLYCEMICS.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Glucose Metabolism Dr Lenon T Gwaunza MBChB, BSc (Hons), MSc (UCL)
GLP-1 agonists Ian Gallen Consultant Community Diabetologist
Medications Used in the Treatment of Diabetes Mellitus
Drugs for Type 2 Diabetes – where next after metformin ?
Diabetes Learning Event 7th October 2016
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions?
Diabetes in Older People :
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Lecture on Anti Diabetic Drugs
6.Fat- increased lipolysis, inc FFA
Oral hypoglycemic drugs
Which ED Pills Are Best?. About Oral ED Pills  Currently, Oral ED pills contain three ED drugs that belong to PDE5 inhibitor class of therapeutic agents.ED.
Injectable Therapies in Diabetes
Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence.
Oral Hypoglycemic Drugs
oral hypoglycemic agents
GLP-1 Agonists and DPP-4 Inhibitors How do they work?
GLP-1 Agonists and DPP-4 Inhibitors How do they work?
Pathophysiology and drug targets.
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Part 5.
Presentation transcript:

Drugs used in Diabetes Dr Sally Hudson

BIGUANIDES reduce output of glucose from the liver and enhances uptake and use of glucose by muscle cells ExampleADVANTAGESDISADVANTAGESCOSTCaution Metformin 500mg/850mg/1g ORAL Weight reduction No hypo’s UKPDS evidence Hba1c 1.5% Nausea, vomiting abdo. Pain, diarrhoea,anorexia/ loss apetite Risk lactic acidosis Avoid eGRF<30 CHEAPRenal failure Hepatic failure and alcoholism as increase risk of lactic acidosis Metformin M/R 500mg,750mg,1g ORAL Once daily Weight reduction No hypo’s Still GI side effects Less than standard formulation Risk lactic acidosis ModerateRenal failure

SULPHONYLUREAS stimulate insulin release from the pancreas. ExampleADVANTAGESDISADVANTAGESCOSTCaution GLICLAZIDE 80MG RAPID ONSET ACTION ORAL Hba1c HYPO’S WEIGHT GAIN GI SIDE EFFECTS LIVER FUNCTION CHEAPELDERLY DRIVERS GLICLAZIDE m/R 30MG ONCE DAILY ORAL

Postprandial glucose regulators Postprandial glucose regulators stimulate a rapid, short duration release of insulin from the pancreas. This helps to restore the normal physiological insulin response to meals. Example ADVANTAGESDISADVANTAGESCOSTCaution Repaglinide 500mcg 30min before meals Up to 4mg as single dose Reduce post prandial BG Reduce Hba1c up to 2% Suitable patient erratic lifestyle or hypo’s on sulphonylureas Weight gain hypoglycaemia cheapRenal impairment hepatic impairment

THIAZOLINDIONES(GLITAZONES) Thiazolidinediones reduce insulin resistance in adipose, skeletal, and hepatic tissues by increasing transcription of insulin sensitive genes in these cells. ExampleADVANTAGESDISADVANTAGESCOSTCaution PIOGLITAZONE 15MG.30MG, 45MG ONCE DAILY ORAL IMPROVED LIPID PROFILE % Hba1c WEIGHT GAIN Fracture risk Risk heart failure Anaemia maculopathy EXPENSIVECi HEARTFAILURE

DPP-4 INHIBITORS block the action of DPP-4 which increases the availability of GLP-1. ExampleADVANTAGESDISADVANT AGES COSTCaution SITAGLIPTIN (januvia) WEIGHT NEUTRAL ONCE DAILY 100mg ORAL Improves fasting glucose Improves B cell function (Triple therapy licence metformin,gliclazide,glitaz one) Mono therapy licence if unable to take metformin. GI SIDE EFFECTS NASOPHARY NGITIS EXPENSIVEAdverse effects pancreatitis Vildagliptin (galvus) Saxagliptin (onglyza)

INCRETIN MIMETICS Beta cells: Enhances glucose-dependent insulin secretion Stomach: Helps slow gastric emptying Liver: ↓ Glucagon which reduces hepatic glucose output Alpha cells: ↓ Postprandial glucagon secretion Promotes satiety and reduces appetite. ExampleADVANTAGESDISADVANTAGESCOSTCaution EXENATIDELOW HYPO RISK WEIGHT LOSS INJECTED TWICE DAILY NAUSEA BLOATING EXPENSIVEPANCREATITIS Severe renal impairment LIRAGLUTIDEONCE DAILY LOW HYPO RISK WEIGHT LOSS BP REDUCTION INJECTED NAUSEA BLOATING EXPENSIVEPANCREATITITS MEDULLARY THYROID CA Severe renal impairment

INSULIN ExampleADVANTAGESDISADVANTAGESCOSTCaution LONG ACTING ANALOGUES LANTUS AND LEVEMIR Effective Tailored regime HYPO RISK WEIGHT GAIN Lantus cancer risk moderateHGV/PSV DRIVERS Short acting Humalog novorapid Reduces postprandial glucose Rapid Use as part of basal bolus Weight gain Hypo’s moderate Mixed Humalog mix 25 Novomix 30 Only twice dailyLess flexible Hypo’s moderate

Erectile impotence PDE5 inhibitors NameDosedurationCautionCISE Sildenafil Viagra mg Single dose 1 hour before intercourse Take on empty stomach Onset action 25 min delayed if taking food Duration action 4-5 hours CVD Anatomical deformation penis Predisposition to priapism Not in patients on nitrates. Within 4 hours of alpha blockesr Indigestion Headache facial flushing Tadalafil Cialis 10mg-20mg at least 30min before max- 20mg in 24 hours Onset action min Duration 36 hours Not in patients on nitrates. Alpha blockers Indigestion Headache Vardenafil levitra 5-20mg min before Can eat/drink Onset action 25 min. Delayed by fatty meal. Duration 4-5 hours Not in patients on nitrates. Alpha blockers Headache facial flushing